Cassava Sciences, Inc.
SAVA
$2.73
$0.155.81%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -42.62M | 17.68M | 972.00K | 16.23M | -68.64M |
| Gross Profit | 42.62M | -17.68M | -972.00K | -16.23M | 68.64M |
| SG&A Expenses | -943.00K | 14.05M | 46.20M | 3.70M | 3.96M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.59M | 31.72M | 61.40M | 19.93M | 22.69M |
| Operating Income | -19.59M | -31.72M | -61.40M | -19.93M | -22.69M |
| Income Before Tax | -27.60M | -27.94M | 6.16M | 25.04M | -20.92M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -27.60M | -27.94M | 6.16M | 25.04M | -20.92M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -27.60M | -27.94M | 6.16M | 25.04M | -20.92M |
| EBIT | -19.59M | -31.72M | -61.40M | -19.93M | -22.69M |
| EBITDA | -19.33M | -31.46M | -61.10M | -19.62M | -22.33M |
| EPS Basic | -0.57 | -0.58 | 0.13 | 0.58 | -0.50 |
| Normalized Basic EPS | -0.23 | -0.38 | 0.08 | 0.36 | -0.31 |
| EPS Diluted | -0.57 | -0.58 | 0.13 | -0.43 | -0.50 |
| Normalized Diluted EPS | -0.23 | -0.38 | 0.08 | 0.35 | -0.31 |
| Average Basic Shares Outstanding | 48.10M | 47.98M | 46.20M | 43.00M | 42.19M |
| Average Diluted Shares Outstanding | 48.10M | 47.98M | 46.20M | 44.10M | 42.19M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
